BioMarin to buy rare disease focused Amicus for $4.8B
BioMarin said Friday it would purchase Amicus Therapeutics for $4.8 billion, merging two rare disease-focused biotechs founded around the turn ...
BioMarin said Friday it would purchase Amicus Therapeutics for $4.8 billion, merging two rare disease-focused biotechs founded around the turn ...
Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat valvular heart disease significantly improved ...
Hot weather can bring more than just discomfort — it can lead to serious health dangers. Heatstroke and heat exhaustion ...
Many serious illnesses begin with subtle early symptoms that people often dismiss as normal stress, aging, or temporary discomfort. These ...
A massive study of more than 11 million U.S. veterans reveals that treating sleep apnea early with CPAP may help ...
Coronary Artery Disease (CAD) remains a leading cause of death globally, but the treatments are rapidly changing. While traditional methods ...
For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a ...
Induced periodontitis prompts severe bone destruction in male mice. Credit: Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas.250709212 ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
The 62 children who were found to have the rare "Bubble Boy disease" as babies and toddlers between 2012 and ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.